Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 4, No 2 (2012) Clinical characteristics of multiple sclerosis in the Tomsk region Abstract  similar documents
V M Alifirova, M A Titova
"... Two hundred and eighty patients (102 men and 178 women; mean age 38.8ё0.7 years) with multiple ..."
 
Vol 8, No 3 (2016) Epidemiology of multiple sclerosis in the Bryansk Region Abstract  similar documents
Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina
"... Objective: to study the clinical and epidemiological features of multiple sclerosis (MS ..."
 
Vol 9, No 1 (2017) Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region Abstract  similar documents
V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev
"... Objective: to analyze the regional register of patients with multiple sclerosis (MS) in the Kursk ..."
 
Vol 10, No 4 (2018) Environmental factors and a risk for multiple sclerosis in the Altai Territory Abstract  similar documents
I. P. Saldan, I. V. Smagina, S. A. Elchaninova
"... Multiple sclerosis (MS) is a chronic dysimmune neurodegenerative disease of the central nervous ..."
 
Vol 11, No 3 (2019) Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis Abstract  similar documents
A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
"... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..."
 
Vol 6, No 3 (2014) Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis Abstract  similar documents
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova
"... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..."
 
Vol 7, No 1 (2015) Time course of changes in the development of gait disorders in multiple sclerosis Abstract  similar documents
A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova
"... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..."
 
Vol 8, No 2 (2016) Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies Abstract  similar documents
N. Yu. Lashch, A. N. Boiko
"... Multiple sclerosis (MS) is a demyelinating disease of the CNS, which affects mainly young able ..."
 
Vol 8, No 3 (2016) Cardiointervalography in patients with multiple sclerosis Abstract  similar documents
A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov
"... Cardiovascular autonomic symptoms significantly impart quality of life in patients with multiple ..."
 
Vol 3, No 2 (2011) Psychological features of patients with central pain syndrome in multiple sclerosis Abstract  similar documents
Maksim Valer'evich Churyukanov, V V Alekseev, M L Kukushkin, N N Yakhno, Maksim Valeryevich Churyukanov, V V Alekseyev, M L Kukushkin, N N Yakhno
"... ) in multiple sclerosis (MS). There was a variety of the clinical manifestations of CPS. An association of pain ..."
 
Vol 6, No 2 (2014) Predementia states and dementia in young people Abstract  similar documents
A.A. Smirnov, A.V. Gustov, S.V. Kopishinskaya, V.A. Antonova
"... in patients with neuroAIDS, Huntington’s disease, or multiple sclerosis. ..."
 
Vol 7, No 1S (2015): Special issue "Epilepsy" Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy Abstract  similar documents
Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov
"... Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years ..."
 
Vol 7, No 1 (2015) Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use Abstract  similar documents
I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova
"... of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers ..."
 
Vol 8, No 1 (2016) Multiple sclerosis-related fatigue and possibilities of its correction Abstract  similar documents
N. Yu. Lashch, A. N. Boiko
"... Multiple sclerosis (MS)-related fatigue is encountered in 75–92% of patients and it is one ..."
 
Vol 8, No 4 (2016) USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev
"... dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic ..."
 
Vol 10, No 1 (2018) New drugs for anti-B-cell therapy of multiple sclerosis Abstract  similar documents
A. N. Boyko, N. Yu. Lashch, M. E. Guseva
"... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..."
 
Vol 11, No 1 (2019) Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis Abstract  PDF (Eng)  similar documents
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko
"... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..."
 
Vol 8, No 4 (2016) GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS Abstract  similar documents
T. E. Shmidt
"... Multiple sclerosis (MS) is the most common and potentially disabling disease of the central ..."
 
Vol 7, No 3 (2015) Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev
"... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..."
 
Vol 10, No 3 (2018) Balo's concentric sclerosis: a clinical case Abstract  PDF (Eng)  similar documents
I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin
"... of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years ..."
 
Vol 10, No 2 (2018) CLIPPERS syndrome Abstract  similar documents
T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno
 
1 - 21 of 21 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)